arcturusrx.com

# Arcturus Therapeutics: Building Next Generation RNA Medicines

> Arcturus Therapeutics is a commercial messenger RNA medicines company focused on the development of infectious disease vaccines\.

Generated by Yoast SEO v28.3, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Careers](https://arcturusrx.com/careers/)
- [About Arcturus](https://arcturusrx.com/about-arcturus/)
- [Business Development](https://arcturusrx.com/mrna-medicines-business-development/)
- [Pipeline](https://arcturusrx.com/mrna-medicines-pipeline/)
- [FAQs](https://arcturusrx.com/about-arcturus/faqs/)

## Posts
- [Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress](https://arcturusrx.com/arcturus-therapeutics-announces-second-quarter-2026-financial-results-and-pipeline-progress/)
- [Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026](https://arcturusrx.com/arcturus-therapeutics-to-report-second-quarter-financial-results-and-provide-corporate-update-on-aug-6-2026/)
- [Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference](https://arcturusrx.com/arcturus-therapeutics-to-present-at-the-canaccord-genuity-46th-annual-growth-conference/)
- [Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT\-032 for Cystic Fibrosis](https://arcturusrx.com/arcturus-therapeutics-announces-strategic-collaboration-with-thermo-fisher-scientific-to-advance-arct-032-for-cystic-fibrosis/)
- [Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference](https://arcturusrx.com/arcturus-therapeutics-to-present-at-2026-jefferies-global-healthcare-conference/)

## Publications
- [LUNAR® LNP delivery of CFTR mRNA restores channel function and improves mucociliary clearance in human and ferret cystic fibrosis airways](https://arcturusrx.com/publications/in-press-lunar-lnp-delivery-of-cftr-mrna-restores-channel-function-and-improves-mucociliary-clearance-in-human-and-ferret-cystic-fibrosis-airways/)
- [Interim Results of Phase 2 Trial of ARCT\-810 mRNA Therapy in Patients with Ornithine Transcarbamylase Deficiency](https://arcturusrx.com/publications/interim-results-of-phase-2-trial-of-arct-810-mrna-therapy-in-patients-with-ornithine-transcarbamylase-deficiency/)
- [Self\-amplifying COVID\-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial](https://arcturusrx.com/publications/self-amplifying-covid-19-mrna-vaccination-induces-longitudinally-enhanced-antibody-function-in-a-phase-3-trial/)
- [LUNAR®\-CF, an aerosolized mRNA replacement Therapy for Cystic Fibrosis Lung Disease](https://arcturusrx.com/publications/4293/)
- [LUNAR®\-CF: An mRNA Replacement Approach for Cystic Fibrosis Lung Disease](https://arcturusrx.com/publications/5707/)

## Publications COVID
- [Differential clearance rate of proteins encoded on a self\-amplifying mRNA COVID\-19 vaccine in muscle and lymph nodes](https://arcturusrx.com/publications_covid/differential-clearance-rate-of-proteins-encoded-on-a-self-amplifying-mrna-covid-19-vaccine-in-muscle-and-lymph-nodes/)
- [Targets of T Cell Responses to SARS\-CoV\-2 Coronavirus in Humans with COVID\-19 Disease and Unexposed Individuals](https://arcturusrx.com/publications_covid/targets-of-t-cell-responses-to-sars-cov-2-coronavirus-in-humans-with-covid-19-disease-and-unexposed-individuals/)
- [A SARS\-CoV\-2 surrogate virus neutralization test based on antibody\-mediated blockage of ACE2–spike protein–protein interaction](https://arcturusrx.com/publications_covid/a-sars-cov-2-surrogate-virus-neutralization-test-based-on-antibody-mediated-blockage-of-ace2-spike-protein-protein-interaction/)
- [An evaluation of COVID\-19 serological assays informs future diagnostics and exposure assessment](https://arcturusrx.com/publications_covid/an-evaluation-of-covid-19-serological-assays-informs-future-diagnostics-and-exposure-assessment/)
- [COVID\-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses](https://arcturusrx.com/publications_covid/covid-19-immune-signatures-reveal-stable-antiviral-t-cell-function-despite-declining-humoral-responses/)

## Page Taxonomies
- [Video Banner](https://arcturusrx.com/b2c/video_banner/)

## Optional
- [Sitemap index](https://arcturusrx.com/sitemap_index.xml)